Recent 8-K filings for YBGJ
Highest-materiality recent filing
Yubo International sells 1,638,458 shares at $0.50 to raise $819,229
- Securities Purchase Agreement with World Precision Medicine Technology Limited for 1,638,458 Class A common shares.
- Purchase price of $0.50 per share for gross proceeds of $819,229.
-
Yubo International Biotech replaces auditor HHL with HCL after going-concern note
HHL LLP resigned as auditor on January 13, 2026; HCL PLLC engaged same day.
-
Yubo to issue 50.6M shares to insiders at $0.05/share for debt cancellation
Issuance of 50.6M shares to FlyDragon and ChinaOne, wholly owned by President Jun Wang and CEO Yang Wang.
-
Yubo International amends 8-K to correct new auditor name; dismisses MTS CPA, engages HHL LLP
Dismissed MTS CPA as auditor effective Jan 2, 2025 due to retirement of Mr. Studer.
-
Dismissal of Michael T. Studer CPA P.C. effective Jan 2, 2025; prior auditor's reports contained a going concern explanatory paragraph.
-
Yubo International amends share agreement to settle $819,229 in loans with World Precision Medicine
Gross proceeds of $819,229 from 1,638,458 shares at $0.50 will settle all outstanding loan principal and accrued interest.
-
Selling stockholders complete sale of 10.5M shares of Yubo common stock at $0.50 each
Focus Draw Group sold 4,728,000 shares; DragonCloud sold 5,768,100 shares.
-
Yubo International sells 1,638,458 shares at $0.50 to raise $819,229
Securities Purchase Agreement with World Precision Medicine Technology Limited for 1,638,458 Class A common shares.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.60 · Most common event other_material